Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-13-000055
Filing Date
2013-11-07
Accepted
2013-11-07 13:26:28
Documents
4
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 6-K THIRD QUARTER 2013 thirdquarter2013.htm 6-K 22438
2 THIRD QUARTER 2013 INTERIM FINANCIAL STATEMENTS ex991interimfinancialstate.htm EX-99.1 382154
3 THIRD QUARTER MD&A 2013 ex992-q32013mda.htm EX-99.2 224368
4 image0.jpg GRAPHIC 32654
  Complete submission text file 0001129928-13-000055.txt   675076
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 131199721
SIC: 2834 Pharmaceutical Preparations